- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: sarcomatous mesothelioma
Total 562 results
-
Åslaug HellandBristol-Myers Squibb; Oslo University Hospital; Ultimovacs ASAActive, not recruitingCancer | Mesothelioma | Mesotheliomas Pleural | Cancer of Lung | Cancer, Lung | Mesothelioma; Pleura | Mesothelioma; LungNorway, Denmark, Sweden, Spain, Australia
-
NeoTX Therapeutics Ltd.AstraZenecaActive, not recruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Ovarian Cancer | NSCLC | Prostate Cancer | Mesothelioma | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Colorectal Cancer Metastatic | Head and Neck Squamous Cell Carcinoma | Urothelial Cancer | Cervical Squamous... and other conditionsIsrael
-
Verastem, Inc.TerminatedMalignant Pleural MesotheliomaUnited States
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPleural Malignant MesotheliomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenelux CorporationActive, not recruiting
-
Capital Medical UniversityTerminatedCancer | Mesothelioma, MalignantChina
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
National Cancer Institute (NCI)WithdrawnMalignant Pleural Mesotheliomas (Mpm) | Malignant Pleural Effusions (Mpe) | Epithelial Tumors, Malignant | Pleural Effusions, Malignant | Mesothelin (Msln)United States
-
Amphera BVTMC PharmaCompletedMesotheliomaNetherlands, France, United Kingdom, Belgium, Italy
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMesothelioma | Malignant Pleural MesotheliomaUnited States
-
Dana-Farber Cancer InstituteAstraZenecaSuspendedMesotheliomaUnited States
-
University of PennsylvaniaNational Institutes of Health (NIH); Tmunity Therapeutics, a wholly owned subsidiary...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Lung Adenocarcinoma | Peritoneal Carcinoma | Mesotheliomas Pleural | Mesothelioma PeritoneumUnited States
-
Deciphera Pharmaceuticals LLCCompletedLocally Advanced or Metastatic Solid TumorUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
Prelude TherapeuticsActive, not recruitingSarcoma | Breast Cancer | Glioblastoma | Malignant Mesothelioma | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung CancersUnited States, Singapore
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC; Intergroupe Francophone de Cancerologie Thoracique; National...Active, not recruitingMesotheliomaFrance, Canada, Italy
-
National Cancer Institute (NCI)Active, not recruitingPleural Malignant MesotheliomaUnited States, Canada
-
University Hospital Southampton NHS Foundation...British Lung Foundation; University of SouthamptonActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedNon Small Cell Lung Cancer | MesotheliomaNetherlands
-
University of ChicagoCompletedMesothelioma | Peritoneal MesotheliomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Unresectable MesotheliomaUnited States
-
Endeavor Biomedicines, Inc.Active, not recruitingSolid Tumors With PTCH1 Loss-of-function MutationsUnited States
-
PrECOG, LLC.AstraZeneca; University of Sydney; Thoracic Oncology Group Australasia (TOGA)Active, not recruitingMesothelioma | Malignant Pleural Mesothelioma | Pleural MesotheliomaUnited States, Australia, New Zealand
-
Roswell Park Cancer InstituteLumeda,Inc.Active, not recruitingMalignant Mesothelioma | Non-Small Cell Lung Carcinoma | Pleural DisorderUnited States
-
NRG OncologyNational Cancer Institute (NCI)TerminatedPleural Biphasic Mesothelioma | Pleural Epithelioid Mesothelioma | Stage I Pleural Malignant Mesothelioma AJCC v8 | Stage IA Pleural Malignant Mesothelioma AJCC v8 | Stage IB Pleural Malignant Mesothelioma AJCC v8 | Stage II Pleural Malignant Mesothelioma AJCC v8 | Stage IIIA Pleural Malignant...United States, Canada
-
Turnstone Biologics, Corp.TakedaTerminatedRenal Cell Carcinoma | Cervical Cancer | Solid Tumor | Mesothelioma | Melanoma (Skin) | Oropharynx Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Microsatellite Stable Colorectal Cancer | Cutaneous Squamous Cell CarcinomaUnited States, Canada, Korea, Republic of
-
Vastra Gotaland RegionAdvanced Accelerator ApplicationsActive, not recruitingThymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase ISweden
-
Dana-Farber Cancer InstituteSuspendedLung Cancer | Prostate Cancer | Mesothelioma | Liver Metastases | Pancreas Cancer | Renal Cancer | Brain Metastases | Spine Metastases | Borderline Resectable Pancreatic Carcinoma | Adrenal Metastases | Oligoprogressive Nodal Metastases | Metachronous Nodal Metastases | Synchronous Nodal MetastasesUnited States
-
University Health Network, TorontoActive, not recruiting
-
Massachusetts General HospitalConquer Cancer FoundationActive, not recruitingStage IV Non-Small Cell Lung Cancer | Stage IV Bladder Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Immunotherapy | Immune Checkpoint Inhibitors | Stage IV Gastric Cancer | Stage IV Merkel Cell Carcinoma | Stage IV Colorectal Cancer | Stage IV Esophageal Cancer | Advanced Lung Cancer | Stage IV Renal... and other conditionsUnited States
-
Groupe Français de Pneumo-CancérologieBristol-Myers SquibbActive, not recruitingMalignant Pleural Mesothelioma | Unresectable Malignant NeoplasmFrance
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedMalignant Mesothelioma (MPM)United States
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
Massachusetts General HospitalCompletedSmall Cell Lung Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Mesothelioma | Non-small Cell Lung Cancer | Liver CancerUnited States
-
Abant Izzet Baysal UniversityCompletedPregnancy | Cesarean Section | Anesthesia, SpinalTurkey
-
Polaris GroupCompletedMesotheliomaUnited States, United Kingdom, Taiwan, Australia, Italy
-
University Hospital, ToulouseCompletedMalignant Mesothelioma | Bronchial CancerFrance
-
University of FloridaGlaxoSmithKlineCompletedRenal Cell Carcinoma | Mesothelioma | Cholangiocarcinoma | Uveal MelanomaUnited States
-
University of HullCompletedLung Neoplasm Malignant | Mesothelioma; LungUnited Kingdom
-
University of ChicagoActive, not recruitingMesothelioma | Peritoneal MesotheliomaUnited States
-
University of ChicagoSuspended
-
Candel Therapeutics, Inc.University of PennsylvaniaCompletedBreast Cancer | Ovarian Cancer | Lung Cancer | Mesothelioma | Malignant Pleural EffusionUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedAdvanced Malignant Pleural MesotheliomaUnited Kingdom
-
BayerTerminatedSolid TumorsUnited States, Italy, France, Poland
-
NCIC Clinical Trials GroupPfizerCompletedMalignant Pleural MesotheliomaCanada
-
National Cancer Institute (NCI)CompletedEpithelioid Mesothelioma | Cholangiocarcinoma, Extrahepatic | Neoplasms With Mesothelin Expression | Adenocarcinoma, PancreaticUnited States
-
Stanford UniversityEnrolling by invitationCarcinoma, Non-Small-Cell Lung | Thymic Carcinoma | Thymoma | Lung Cancer | Mesothelioma | Thymus CancerUnited States
-
PrECOG, LLC.AstraZenecaCompletedMesothelioma | Pleural MesotheliomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); North Central Cancer Treatment GroupCompletedPemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaMesotheliomaUnited States